Mwanyalu Nassoro, Nunga Maria, Mwanyamawi Raphael, Abdallah Saade, Owiny Maurice
Department of Health Service, Mombasa County, Mombasa, Kenya.
Field Epidemiology and Laboratory Training Program, Ministry of Health, Nairobi, Kenya.
Adv Drug Alcohol Res. 2024 Jun 7;4:11791. doi: 10.3389/adar.2024.11791. eCollection 2024.
The Methadone Maintenance Treatment (MMT) program has been proven to be beneficial in reducing illicit opioid use, increasing access to and retention of HIV treatment and other therapies, and reducing HIV transmission, and other drug-related morbidities and mortalities. However, determinants of treatment retention and outcomes for opioid-dependent persons accessing MMT in Kenya are limited. We sought to identify factors contributing to poor treatment outcomes among opioid-dependent persons enrolled in the Mombasa MMT program, between 2017 and 2019. We conducted a retrospective records review for opioid-dependent persons receiving Methadone treatment in the Kisauni MAT clinic enrolled during 2017-2019. We defined poor clinical or health-related treatment outcome as any client Lost-To-Follow-Up (LTFU), turned HIV or Viral hepatitis positive, and/or missed two or more antiretroviral therapy (ART) appointments intake during MMT. Variables abstracted from clinical and pharmacological MMT service delivery tools included socio-demographic characteristics, clinical history, risk factors, and MMT outcomes. Data were analyzed using . We calculated Prevalence Odds Ratios (POR) and 95% Confidence Intervals (CI) to identify factors associated with adverse health outcomes. Of the total 443 eligible records, the mean age was 37 years (SD ± 7.2) and males comprised 90.7%. The majority of females clients, 79.1% (34/43), were aged ≤35 years, 7.0% (3/43) had no education, 32.6% (14/43) were employed, 39.5% (17/43) were HIV positive and 18.6% (8/43) were HCV-positive. Overall, adverse treatment outcomes were at 27.5% (122/443), namely: LTFU at 22.8% (101/443), new HIV cases at 1.0% (4/391), HCV at 1.2% (5/405), and Hepatitis B Virus (HBV) at 1.2% (5/411), and 1.1% (5/443) died. Of HIV-infected clients linked to Comprehensive Care Clinic (CCC), 3.6% (2/56) defaulted from ART, and 25% (2/8) had detectable Viral Load of those retested. Lack of formal education (POR: 2.7, 95% CI: 1.3-5.7), unemployment (POR: 2.4, 95% CI: 1.4-4.0), and being a Non-Injector (POR: 1.7, 95% CI: 1.0-2.9) were negatively associated with treatment retention. Females were younger, and more educated with higher HIV and HCV prevalence. Being a Non-injector, unemployment, and lack of formal education may increase the likelihood of poor treatment outcomes among MMT clients. Closer monitoring of MMT clients with these characteristics is recommended with the integration of CCC into MMT services.
美沙酮维持治疗(MMT)项目已被证明在减少非法阿片类药物使用、增加获得和维持艾滋病毒治疗及其他疗法的机会、减少艾滋病毒传播以及其他与药物相关的发病率和死亡率方面具有益处。然而,在肯尼亚,接受MMT治疗的阿片类药物依赖者的治疗留存率及治疗结果的决定因素尚不清楚。我们试图确定2017年至2019年间在蒙巴萨MMT项目中登记的阿片类药物依赖者治疗效果不佳的影响因素。我们对2017 - 2019年期间在基萨尼美沙酮维持治疗(MAT)诊所接受美沙酮治疗的阿片类药物依赖者进行了回顾性记录审查。我们将不良临床或与健康相关的治疗结果定义为任何失访(LTFU)的患者、艾滋病毒或病毒性肝炎检测呈阳性的患者,以及在MMT期间错过两次或更多次抗逆转录病毒治疗(ART)预约的患者。从临床和药理学MMT服务提供工具中提取的变量包括社会人口学特征、临床病史、风险因素和MMT结果。使用[具体分析方法未给出]进行数据分析。我们计算了患病率比值比(POR)和95%置信区间(CI),以确定与不良健康结果相关的因素。在总共443份符合条件的记录中,平均年龄为37岁(标准差±7.2),男性占90.7%。大多数女性患者,即79.1%(34/43)年龄≤35岁,7.0%(3/43)未接受过教育,32.6%(14/43)有工作,39.5%(17/43)艾滋病毒检测呈阳性,18.6%(8/43)丙型肝炎病毒检测呈阳性。总体而言,不良治疗结果发生率为27.5%(122/443),具体如下:失访率为22.8%(101/443),新增艾滋病毒病例为1.0%(4/391),丙型肝炎病毒感染率为1.2%(5/405),乙型肝炎病毒(HBV)感染率为1.2%(5/411),1.1%(5/443)死亡。在与综合护理诊所(CCC)建立联系的艾滋病毒感染患者中,3.6%(2/56)未坚持接受ART治疗,在接受重新检测的患者中,25%(2/8)病毒载量可检测到。未接受过正规教育(POR:2.7,95% CI:1.3 - 5.7)、失业(POR:2.4,95% CI:1.4 - 4.0)以及非注射吸毒者(POR:1.7,95% CI:1.0 - 2.9)与治疗留存率呈负相关。女性年龄较小,受教育程度较高,艾滋病毒和丙型肝炎病毒感染率较高。非注射吸毒者、失业以及未接受过正规教育可能会增加MMT患者出现不良治疗结果的可能性。建议对具有这些特征的MMT患者进行密切监测,并将CCC纳入MMT服务中。